Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature

Author:

Pecorari Isabella L.12ORCID,Mahali Lakshmi Priyanka34,Funari Abigail12,Fecher Roger56,Suda Nisha34,Agarwal Vijay12

Affiliation:

1. Department of Neurological Surgery, Albert Einstein College of Medicine, Bronx, New York, United States

2. Department of Neurological Surgery, Montefiore Medical Center, Bronx, New York, United States

3. Department of Endocrinology, Albert Einstein College of Medicine, Bronx, New York, United States

4. Department of Endocrinology, Montefiore Medical Center, Bronx, New York, United States

5. Department of Anatomic and Clinical Pathology, Albert Einstein College of Medicine, Bronx, New York, United States

6. Department of Anatomic and Clinical Pathology, Montefiore Medical Center, Bronx, New York, United States

Abstract

AbstractClinically silent double pituitary adenomas consisting of corticotroph and somatotroph cells are an exceedingly rare clinical finding. In this report, we present the case of a 28-year-old man with a 1-year history of recurrent headaches. Imaging revealed a 2.1 (anterior-posterior) × 2.2 (transverse) × 1.3 (craniocaudal) cm pituitary adenoma invading into the left cavernous sinus and encasing the left internal carotid artery. Endoscopic transnasal resection was performed without complications. Immunohistochemical staining revealed a double adenoma consisting of distinct sparsely granulated somatotroph and densely granulated corticotroph cells that were positive for growth hormone and adrenocorticotropic hormone, respectively. Ki-67 index labeling revealed a level of 6% within the corticotroph adenoma. No increase in serum growth hormone or adrenocorticotropic hormone was found, indicating a clinically silent double adenoma. While transsphenoidal surgery remains a first-line approach for silent adenomas presenting with mass effects, increased rates of proliferative markers, such as the Ki-67 index, provide useful insight into the clinical course of such tumors. Determining the Ki-67 index of silent pituitary adenomas could be valuable in predicting recurrence after initial surgical resection and identifying tumors that are at an increased risk of needing additional therapeutic interventions or more frequent surveillance imaging.

Publisher

Georg Thieme Verlag KG

Subject

Neurology (clinical),Surgery

Reference46 articles.

1. Clinical and pathological aspects of silent pituitary adenomas;J Drummond;J Clin Endocrinol Metab,2019

2. Silent (clinically nonfunctioning) pituitary adenomas;S E Mayson;J Neurooncol,2014

3. Subclinical hyperfunctioning pituitary adenomas: the silent tumors;O Cooper;Best Pract Res Clin Endocrinol Metab,2012

4. Dopamine as a prolactin (PRL) inhibitor;N Ben-Jonathan;Endocr Rev,2001

5. Clinically silent somatotroph adenomas are common;A N Wade;Eur J Endocrinol,2011

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3